Skip to main navigation Skip to search Skip to main content

TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug's uncoupler activity

  • Jickky Palmae Sarathy
  • , Priya Ragunathan
  • , Christopher B. Cooper
  • , Anna M. Upton
  • , Gerhard Gruber
  • , Thomas Dick
  • National University of Singapore
  • Nanyang Technological University
  • Global Alliance for TB Drug Development (TB Alliance)

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

The diarylquinoline F1FO-ATP synthase inhibitor bedaquiline (BDQ) displays protonophore activity. Thus, uncoupling electron transport from ATP synthesis appears to be a second mechanism of action of this antimycobacterial drug. Here, we show that the new BDQ analogue TBAJ-876 did not retain the parental drug's protonophore activity. Comparative time-kill analyses revealed that both compounds exert the same bactericidal activity. These results suggest that the uncoupler activity is not required for the bactericidal activity of diarylquinolines.

Original languageEnglish
Article numbere01540
JournalAntimicrobial Agents and Chemotherapy
Volume64
Issue number2
DOIs
StatePublished - 27 Jan 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bedaquiline
  • Protonophore
  • TBAJ-876
  • Tuberculosis
  • Uncoupler

Fingerprint

Dive into the research topics of 'TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug's uncoupler activity'. Together they form a unique fingerprint.

Cite this